-

Seek Labs Announces Completion of Office Expansion to Support Business Growth

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and pharmaceuticals, today announced the successful completion of a significant expansion at its headquarters. The expansion, aimed at fostering innovation and employee growth, has quadrupled the size of the office space and introduced new facilities to support employee well-being.

The expansion, which began in July 2023 and concluded at the end of November, marks a milestone for Seek Labs as it continues to drive diagnostic and pharmaceutical innovation. The new facilities have been thoughtfully designed to enhance collaboration, innovation, and employee satisfaction.

Key features of the expansion include:

  1. Quadrupled Office Space: The existing space nearly quadrupled by adding 16,700 sq. ft. of new office space to the existing 5,000 sq. ft., for a total of over 21,000 sq. ft. of new space. This increased capacity will accommodate the growing needs of Seek Labs and support development of new projects and initiatives.
  2. New Pharmaceutical Laboratory Space: New state-of-the-art laboratory spaces were added, which are intended for ongoing pharmaceutical research. The new pharmaceutical labs will enable the team to conduct cutting-edge research and development, reinforcing Seek Labs' commitment to advancing innovation.
  3. Additional Spaces for Employee Productivity and Well-being: Recognizing the importance of a conducive work environment, Seek Labs has incorporated new spaces to promote employee well-being and productivity. These include dedicated areas for collaboration, meditation, and enhanced amenities to support the team.

"This expansion represents a significant investment in our future and a commitment to providing our team with the resources and environment they need to thrive,” said Jared Bauer, CEO. “The additional space and enhanced facilities will empower us to continue delivering groundbreaking solutions in diagnostics and pharmaceuticals and foster a workplace culture that prioritizes both innovation and well-being. We hope the increased office space helps us get important products to patients more rapidly."

Seek Labs looks forward to the positive impact the expansion will have on its operations and the continued success of its team. Seek Labs remains dedicated to driving innovation in diagnostic and pharmaceutical technologies that improve outcomes for patients globally. Additionally, Seek Labs is committed to maintaining a workplace that inspires creativity and collaboration.

About Seek Labs

Seek Labs is a company united by a vision to advance scientific discovery and universal solutions. Seek Labs strives to innovate healthcare solutions that bridge gaps between patients, providers, and treatments. Seek Labs is united by the passion of our founders and their shared beliefs that healthcare solutions should empower individuals and serve their specific needs. Today—after years of experimentation, failure, and breakthrough— Seek Labs is developing next generation molecular diagnostics and pharmaceutical technologies that have the potential to revolutionize the detection and treatment of diseases.

Seek Labs is headquartered in Salt Lake City, Utah. Seek Labs is a proud member of the BioHive, a collective representing the life sciences and healthcare innovation ecosystem in Utah. BioHive is dedicated to all the ways our work can positively impact the lives of our community, our teams, and patients.

Contacts

Bridget Baldwin
Director of Communications, Seek Labs
bridget@seeklabs.com

Seek Labs


Release Versions

Contacts

Bridget Baldwin
Director of Communications, Seek Labs
bridget@seeklabs.com

Social Media Profiles
More News From Seek Labs

Seek Labs Announces Publication in Nature Communications Validating ANINA™, a Room-Temperature, Instrument-Free Amplification Diagnostic Technology Designed to Deliver PCR-Level Sensitivity at the Point of Need

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, announced the publication of a peer-reviewed manuscript in Nature Communications describing Annexing Isothermal Nucleotide Amplification (ANINA™), the proprietary amplification chemistry that powers its SeekIt™ molecular diagnostic platform. The publication, titled “Annexing Isothermal Nucleotide Amplification (ANINA) Enables Probe-Guided Amplification...

Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced it has mapped CRISPR-addressable regions across 25 out of 25 viral families known to infect humans, creating a comprehensive atlas of viral genetic vulnerabilities that may support faster identification of antiviral target sites against known pathogens, emerging variants, and future outbreak threats. Antiviral development has been reacti...

Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the United States Patent and Trademark Office has issued U.S. Patent No. 12,618,795 B2, covering Asymmetric Semi-Nested Isothermal Nucleotide Amplification (ANINA), a key assay design component of the company’s nucleic acid amplification chemistry for use in molecular diagnostic systems, called Seek Amplification™. Molecular diagnostics...
Back to Newsroom